News

The Centenary Institute recently hosted the 2026 Tuberculosis Centre of Research Excellence (TB-CRE) Annual Research Symposium. The event brought together leading researchers, clinicians and tuberculosis (TB) program partners dedicated to tackling TB across Australia and the Asia-Pacific region.

The Centenary Institute’s Associate Professor Dan Hesselson has been awarded $750,000 to accelerate pioneering research into heart regeneration, through a prestigious Senior Researcher Grant under the NSW Cardiovascular Research Capacity Program, funded by NSW Health.

The Centenary Institute recently welcomed Justin Clancy MP, Shadow Minister for Medical Research on-site, providing laboratory tours and a firsthand look at research focused on improving health outcomes for Australians.

The Centenary Institute is implementing a new research program aimed at improving the diagnosis and care of women experiencing heavy menstrual bleeding.

Researchers from the Centenary Institute and Tianjin Medical University have uncovered an important communication pathway inside the liver that helps control fat build-up, offering a promising new direction for tackling fatty liver disease.

Researchers at the Centenary Institute have discovered that fibrinogen, a key blood clotting protein, is far more complex than previously understood, offering new insight into how blood clots form in the body.

For Dr Xin (Tracy) Liu, fatty liver disease isn’t just a scientific challenge, it’s personal. Inspired by family members affected by metabolic conditions, she’s now a key member of Australia’s seven‑year Snow Program for Liver Health.

Researchers at the Centenary Institute have helped uncover a previously unrecognised genetic cause of sudden cardiac death in young people.

Dr Lise Hunault, a researcher in the Centenary Institute’s Centre for Biomedical AI, has been awarded a major research grant from Breakthrough T1D, the leading global type 1 diabetes research and advocacy organisation, to advance islet-cell replacement therapies for type 1 diabetes.

The Centenary Institute community came together to celebrate International Women’s Day 2026, with a special event highlighting this year’s Australian theme, ‘Balancing the Scales.’

A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.

The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.